"Partnering with the Australian Stroke Alliance and their world-leading clinical experts is a major step toward delivering rapid endovascular care to stroke and cardiovascular patients in Australia ...
NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Remedy Pharmaceuticals, a leader in stroke drug development today announced efficacy data from the Phase 2 GAMES-RP and Phase 3 CHARM studies of CIRARA ...
Through this partnership, Remedy will become Mission Thrombectomy's exclusive robotics partner and work in close collaboration with Mission Thrombectomy's world-leading clinical network, which ...
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for kidney diseases and neurological ...
The Houston-based startup is developing capabilities for endovascular aneurysm repair and stroke treatment that it hopes can ...
Artificial intelligence is revolutionizing stroke care in India by accelerating diagnosis and treatment within the critical ...
Fast highlights the most common warning signs of stroke, but some strokes present differently. To make sure fewer cases are ...
Remedy Robotics has been selected by the Australian Stroke Alliance as its exclusive robotics partner to expand access to endovascular thrombectomy, the gold standard in stroke care SAN FRANCISCO and ...
Remedy Robotics selected as Mission Thrombectomy's exclusive robotics partner to broaden access to life-saving stroke treatment in the U.S. and across the world SAN FRANCISCO and WASHINGTON, Oct. 27, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results